Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
$10.16
-4.4%
$7.62
$4.61
$11.04
$207.53M1.82177,809 shs225,946 shs
Inogen, Inc stock logo
INGN
Inogen
$8.11
-0.1%
$7.14
$5.70
$12.91
$219.29M1.78232,119 shs251,175 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.23
+1.6%
$4.21
$3.03
$9.33
$53.10M1.41196,176 shs55,083 shs
Neuronetics, Inc. stock logo
STIM
Neuronetics
$3.23
-2.4%
$3.74
$0.52
$5.92
$213.58M1.281.37 million shs1.89 million shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
0.00%-5.75%+35.11%+66.28%+65.20%
Inogen, Inc stock logo
INGN
Inogen
0.00%+1.50%+38.16%+23.07%-30.03%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
0.00%-4.72%-39.63%-34.35%-48.07%
Neuronetics, Inc. stock logo
STIM
Neuronetics
0.00%-3.00%-19.45%-13.17%+292.75%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
$10.16
-4.4%
$7.62
$4.61
$11.04
$207.53M1.82177,809 shs225,946 shs
Inogen, Inc stock logo
INGN
Inogen
$8.11
-0.1%
$7.14
$5.70
$12.91
$219.29M1.78232,119 shs251,175 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.23
+1.6%
$4.21
$3.03
$9.33
$53.10M1.41196,176 shs55,083 shs
Neuronetics, Inc. stock logo
STIM
Neuronetics
$3.23
-2.4%
$3.74
$0.52
$5.92
$213.58M1.281.37 million shs1.89 million shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
0.00%-5.75%+35.11%+66.28%+65.20%
Inogen, Inc stock logo
INGN
Inogen
0.00%+1.50%+38.16%+23.07%-30.03%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
0.00%-4.72%-39.63%-34.35%-48.07%
Neuronetics, Inc. stock logo
STIM
Neuronetics
0.00%-3.00%-19.45%-13.17%+292.75%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
4.00
Strong Buy$12.5023.03% Upside
Inogen, Inc stock logo
INGN
Inogen
2.50
Moderate Buy$11.0035.64% Upside
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.00
Buy$8.00147.68% Upside
Neuronetics, Inc. stock logo
STIM
Neuronetics
3.00
Buy$7.00116.72% Upside

Current Analyst Ratings Breakdown

Latest SRTS, STIM, INFU, and INGN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/12/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$12.00 ➝ $8.00
8/8/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$13.00 ➝ $6.00
8/6/2025
Neuronetics, Inc. stock logo
STIM
Neuronetics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$8.00 ➝ $7.00
7/22/2025
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$12.00
7/21/2025
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
6/16/2025
Inogen, Inc stock logo
INGN
Inogen
B. Riley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$14.00
6/15/2025
Inogen, Inc stock logo
INGN
Inogen
B. Riley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$14.00
(Data available from 9/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
$139.89M1.48$0.79 per share12.79$2.47 per share4.11
Inogen, Inc stock logo
INGN
Inogen
$335.70M0.65N/AN/A$7.30 per share1.11
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$37.56M1.41$0.43 per share7.48$3.41 per share0.95
Neuronetics, Inc. stock logo
STIM
Neuronetics
$74.89M2.85N/AN/A$0.57 per share5.67
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
$870K$0.23169.3632.77N/A1.12%2.78%1.41%N/A
Inogen, Inc stock logo
INGN
Inogen
-$35.89M-$1.06N/AN/AN/A-7.58%-13.77%-8.52%11/6/2025 (Estimated)
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M-$0.06N/A14.04N/A-2.26%-1.58%-1.41%11/13/2025 (Estimated)
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$43.71M-$1.13N/AN/AN/A-43.47%-156.36%-35.69%11/11/2025 (Estimated)

Latest SRTS, STIM, INFU, and INGN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Inogen, Inc stock logo
INGN
Inogen
-$0.22-$0.15+$0.07-$0.15$90.40 million$92.28 million
8/7/2025Q2 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.01-$0.06-$0.07-$0.06$9.30 million$7.32 million
8/5/2025Q2 2025
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$0.08-$0.15-$0.07-$0.15$36.80 million$38.11 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
N/AN/AN/AN/AN/A
Inogen, Inc stock logo
INGN
Inogen
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
Neuronetics, Inc. stock logo
STIM
Neuronetics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
0.50
1.98
1.59
Inogen, Inc stock logo
INGN
Inogen
N/A
3.03
2.67
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
8.14
5.79
Neuronetics, Inc. stock logo
STIM
Neuronetics
1.76
2.02
1.84

Institutional Ownership

CompanyInstitutional Ownership
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
71.13%
Inogen, Inc stock logo
INGN
Inogen
89.94%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%
Neuronetics, Inc. stock logo
STIM
Neuronetics
53.59%

Insider Ownership

CompanyInsider Ownership
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
11.40%
Inogen, Inc stock logo
INGN
Inogen
1.46%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
Neuronetics, Inc. stock logo
STIM
Neuronetics
8.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
InfuSystem Holdings, Inc. stock logo
INFU
InfuSystem
41020.43 million19.10 millionOptionable
Inogen, Inc stock logo
INGN
Inogen
1,03027.04 million26.65 millionOptionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.44 million14.98 millionOptionable
Neuronetics, Inc. stock logo
STIM
Neuronetics
18066.12 million60.37 millionOptionable

Recent News About These Companies

Neuronetics taps local industry veteran as new CFO
Neuronetics Appoints New Chief Financial Officer

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
InfuSystem stock logo

InfuSystem NYSE:INFU

$10.16 -0.47 (-4.42%)
Closing price 09/5/2025 04:00 PM Eastern
Extended Trading
$10.34 +0.18 (+1.72%)
As of 09/5/2025 06:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

Inogen stock logo

Inogen NASDAQ:INGN

$8.11 -0.01 (-0.12%)
Closing price 09/5/2025 04:00 PM Eastern
Extended Trading
$8.10 0.00 (-0.06%)
As of 09/5/2025 04:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$3.23 +0.05 (+1.57%)
Closing price 09/5/2025 04:00 PM Eastern
Extended Trading
$3.21 -0.02 (-0.62%)
As of 09/5/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Neuronetics stock logo

Neuronetics NASDAQ:STIM

$3.23 -0.08 (-2.42%)
Closing price 09/5/2025 04:00 PM Eastern
Extended Trading
$3.28 +0.05 (+1.52%)
As of 09/5/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.